Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 246 Precursor Cell Lymphoblastic Leukemia-Lymphoma 147 Myelodysplastic Syndromes 144 Leukemia, Lymphocytic, Chronic, B-Cell 140 Leukemia 128 Multiple Myeloma 118 Lymphoma 116 Lymphoma, Non-Hodgkin 112 Recurrence 80 Hematologic Neoplasms 77 Melanoma 68 Hodgkin Disease 68 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 67 Lymphoma, B-Cell 61 Lymphoma, Mantle-Cell 52 Lymphoma, Large B-Cell, Diffuse 50 Lymphoma, Follicular 50 Burkitt Lymphoma 41 Ovarian Neoplasms 40 Neoplasms 39 Myeloproliferative Disorders 39 Neoplasm Metastasis 34 Lymphoma, B-Cell, Marginal Zone 30 Graft vs Host Disease 29 Neoplasms, Plasma Cell 28 Carcinoma, Non-Small-Cell Lung 27 Breast Neoplasms 27 Leukemia, Biphenotypic, Acute 25 Primary Myelofibrosis 24 Anemia, Refractory, with Excess of Blasts 23

Interventions

vandetanib 14 cabozantinib 9 selpercatinib 6 Sorafenib 5 Everolimus 5 pralsetinib 3 Magnetic Resonance Spectroscopy 3 Capecitabine 3 sargramostim 2 lutetium Lu 177 dotatate 2 lenvatinib 2 Trastuzumab 2 Thyroidectomy 2 Temozolomide 2 Sunitinib 2 Specimen Handling 2 Octreotide 2 High-Energy Shock Waves 2 Gefitinib 2 Doxorubicin 2 yeast-CEA vaccine 1 veliparib 1 vatalanib 1 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tipifarnib 1 temsirolimus 1 tanespimycin 1 sacubitril and valsartan sodium hydrate drug combination 1 rovalpituzumab tesirine 1 ponatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Medullary × fludarabine × Clear all

NCT04877613 2025-07-03

GFRα4 CAR T Cells in MTC Patients

University of Pennsylvania

Phase 1 Active not recruiting

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡